<DOC>
	<DOCNO>NCT02608476</DOCNO>
	<brief_summary>The primary objective study determine safety efficacy CB-03-01 cream , 1 % , versus vehicle cream apply twice daily 12 week subject facial acne vulgaris .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy CB-03-01 Cream , 1 % Subjects With Facial Acne Vulgaris ( 26 )</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>1 . Subject male nonpregnant female , 9 year age old . Females must postmenopausal , surgically sterile , use highly effective birth control method . Women childbearing potential must negative urine pregnancy test ( UPT ) Screening/Baseline Visit . 2 . Subject provide write verbal informed consent/assent . A subject 18 year age must provide write informed assent accompany parent legal guardian time assent/consent signing . 3 . Subject Investigator 's Global Assessment ( IGA ) score 3 ( moderate ) 4 ( severe ) [ 0 ( clear ) 4 ( severe ) scale ] . 4 . Subject facial acne vulgaris least 30 maximum 75 inflammatory lesion ( papule , pustule , nodule ) 30 maximum 100 noninflammatory lesion ( open close comedo ) . 5 . Subject parent/guardian ( applicable ) willing comply study instruction return clinic require visit . 6 . Subject use type brand makeup , facial product ( exclusive RX/OTC acne cleanser ) hair product ( e.g. , shampoo , gel , hair spray , mousse , etc . ) least one ( 1 ) month prior Baseline Visit agree continue his/her general skin hair care product regimen entire study . 1 . Subject pregnant , lactating , plan become pregnant study . 2 . Subject skin pathology condition could interfere evaluation test product require use interfere topical systemic therapy . 3 . Subject great two ( 2 ) facial nodule . 4 . Subject nodulocystic acne . 5 . Subject condition , investigator 's opinion , would make unsafe subject participate research study . 6 . Subject currently enrol investigational drug device study . 7 . Subject receive investigational drug treat investigational device within 30 day prior initiation treatment ( Baseline ) . 8 . Subject facial hair could interfere study assessment opinion investigator . 9 . Subject parent/guardian ( applicable ) unable communicate cooperate investigator due language problem , poor mental development , impaired cerebral function . 10 . Subject may unreliable study include subject engage excessive alcohol intake drug abuse , subject unable return schedule followup visit . 11 . Subject know hypersensitivity previous allergic reaction active inactive component test article . 12 . Subject need plan expose artificial tanning device excessive sunlight trial . 13 . Subject use prohibited topical antiacne treatment procedures prior study unless appropriate washout period document . 14 . Subject use use prohibited systemic antiacne medication prior study unless appropriate washout period document .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>acne</keyword>
</DOC>